Francesco Leonforte, Claudio Fiorilla, Gabriele Giorgianni, Vito Nicosia, Fabio Contarino, Cristina Genovese, Giovanni Genovese, Giustino Morlino, Martina Chimienti, Antonio Mistretta
{"title":"流感疫苗接种的适当性:来自卡塔尼亚当地卫生单位在2023/2024和2024/2025季节的见解","authors":"Francesco Leonforte, Claudio Fiorilla, Gabriele Giorgianni, Vito Nicosia, Fabio Contarino, Cristina Genovese, Giovanni Genovese, Giustino Morlino, Martina Chimienti, Antonio Mistretta","doi":"10.3390/vaccines13090925","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background/Objectives</b>: Influenza poses a substantial global public health challenge, disproportionately affecting vulnerable populations. Vaccination is the most effective preventive measure, and recent strategies in Italy emphasize the principle of \"appropriateness\"-the alignment of specific vaccine formulations (e.g., adjuvanted or high-dose) with targeted risk groups to optimize protection. Nevertheless, challenges persist in ensuring the consistent administration of the most suitable vaccine, particularly among high-risk individuals who would benefit most. <b>Methods</b>: A retrospective descriptive study was conducted using data from the 2023-2024 and 2024-2025 influenza vaccination campaigns of the Local Health Authority of Catania. Vaccination data were analyzed by age group and vaccine type, based on national immunization guidelines. Population categories included individuals ≥ 65 years, adults 60-64 years, adults 18-59 years (with/without chronic conditions), children, and pregnant/postpartum women. Vaccine types analyzed were aQIV, QIV-HD, QIV-SD, QIVcc, and LAIV. Descriptive statistics were used, and Relative Risk (RR) with 95% Confidence Intervals (CI) was calculated using the 60-64 age group as a reference. Analyses were performed with Stata 18.0. <b>Results</b>: In 2023-2024, 78.8% of individuals ≥ 65 received recommended vaccines, compared to 100% in the 60-64 group (RR = 0.23; 95% CI: 0.225-0.231). Adults 18-59, children, and pregnant/postpartum women showed ≥99% adherence. In 2024-2025, appropriateness in the ≥65 group improved to 96.1% (RR = 0.12; 95% CI: 0.118-0.128). All other groups maintained high adherence (≥99%), except for 6.2% of children aged 6 months-2 years who inappropriately received LAIV. <b>Conclusions</b>: Despite dramatically improved vaccination appropriateness in the elderly, a persistent and critical safety issue--inappropriate administration LAIV use in 6.2% of young children-highlights the need for targeted interventions to ensure complete patient safety.</p>","PeriodicalId":23634,"journal":{"name":"Vaccines","volume":"13 9","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12474316/pdf/","citationCount":"0","resultStr":"{\"title\":\"Influenza Vaccination Appropriateness: Insights from the Local Health Unit of Catania During the 2023/2024 and 2024/2025 Seasons.\",\"authors\":\"Francesco Leonforte, Claudio Fiorilla, Gabriele Giorgianni, Vito Nicosia, Fabio Contarino, Cristina Genovese, Giovanni Genovese, Giustino Morlino, Martina Chimienti, Antonio Mistretta\",\"doi\":\"10.3390/vaccines13090925\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background/Objectives</b>: Influenza poses a substantial global public health challenge, disproportionately affecting vulnerable populations. Vaccination is the most effective preventive measure, and recent strategies in Italy emphasize the principle of \\\"appropriateness\\\"-the alignment of specific vaccine formulations (e.g., adjuvanted or high-dose) with targeted risk groups to optimize protection. Nevertheless, challenges persist in ensuring the consistent administration of the most suitable vaccine, particularly among high-risk individuals who would benefit most. <b>Methods</b>: A retrospective descriptive study was conducted using data from the 2023-2024 and 2024-2025 influenza vaccination campaigns of the Local Health Authority of Catania. Vaccination data were analyzed by age group and vaccine type, based on national immunization guidelines. Population categories included individuals ≥ 65 years, adults 60-64 years, adults 18-59 years (with/without chronic conditions), children, and pregnant/postpartum women. Vaccine types analyzed were aQIV, QIV-HD, QIV-SD, QIVcc, and LAIV. Descriptive statistics were used, and Relative Risk (RR) with 95% Confidence Intervals (CI) was calculated using the 60-64 age group as a reference. Analyses were performed with Stata 18.0. <b>Results</b>: In 2023-2024, 78.8% of individuals ≥ 65 received recommended vaccines, compared to 100% in the 60-64 group (RR = 0.23; 95% CI: 0.225-0.231). Adults 18-59, children, and pregnant/postpartum women showed ≥99% adherence. In 2024-2025, appropriateness in the ≥65 group improved to 96.1% (RR = 0.12; 95% CI: 0.118-0.128). All other groups maintained high adherence (≥99%), except for 6.2% of children aged 6 months-2 years who inappropriately received LAIV. <b>Conclusions</b>: Despite dramatically improved vaccination appropriateness in the elderly, a persistent and critical safety issue--inappropriate administration LAIV use in 6.2% of young children-highlights the need for targeted interventions to ensure complete patient safety.</p>\",\"PeriodicalId\":23634,\"journal\":{\"name\":\"Vaccines\",\"volume\":\"13 9\",\"pages\":\"\"},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2025-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12474316/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccines\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/vaccines13090925\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/vaccines13090925","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Influenza Vaccination Appropriateness: Insights from the Local Health Unit of Catania During the 2023/2024 and 2024/2025 Seasons.
Background/Objectives: Influenza poses a substantial global public health challenge, disproportionately affecting vulnerable populations. Vaccination is the most effective preventive measure, and recent strategies in Italy emphasize the principle of "appropriateness"-the alignment of specific vaccine formulations (e.g., adjuvanted or high-dose) with targeted risk groups to optimize protection. Nevertheless, challenges persist in ensuring the consistent administration of the most suitable vaccine, particularly among high-risk individuals who would benefit most. Methods: A retrospective descriptive study was conducted using data from the 2023-2024 and 2024-2025 influenza vaccination campaigns of the Local Health Authority of Catania. Vaccination data were analyzed by age group and vaccine type, based on national immunization guidelines. Population categories included individuals ≥ 65 years, adults 60-64 years, adults 18-59 years (with/without chronic conditions), children, and pregnant/postpartum women. Vaccine types analyzed were aQIV, QIV-HD, QIV-SD, QIVcc, and LAIV. Descriptive statistics were used, and Relative Risk (RR) with 95% Confidence Intervals (CI) was calculated using the 60-64 age group as a reference. Analyses were performed with Stata 18.0. Results: In 2023-2024, 78.8% of individuals ≥ 65 received recommended vaccines, compared to 100% in the 60-64 group (RR = 0.23; 95% CI: 0.225-0.231). Adults 18-59, children, and pregnant/postpartum women showed ≥99% adherence. In 2024-2025, appropriateness in the ≥65 group improved to 96.1% (RR = 0.12; 95% CI: 0.118-0.128). All other groups maintained high adherence (≥99%), except for 6.2% of children aged 6 months-2 years who inappropriately received LAIV. Conclusions: Despite dramatically improved vaccination appropriateness in the elderly, a persistent and critical safety issue--inappropriate administration LAIV use in 6.2% of young children-highlights the need for targeted interventions to ensure complete patient safety.
VaccinesPharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
8.90
自引率
16.70%
发文量
1853
审稿时长
18.06 days
期刊介绍:
Vaccines (ISSN 2076-393X) is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization. Vaccines publishes high quality reviews, regular research papers, communications and case reports.